Boundless Bio, Inc. Common Stock Financial Flexibility Index
Boundless Bio, Inc. Common Stock financial flexibility index. Boundless Bio, Inc. Common Stock (BOLD) has a Financial Flexibility Index of -0.17x as of September 2025. Free cash flow of $-10.18 Million (operating CF $-10.20 Million minus capex $15.00K) represents 0% of total liabilities ($58.55 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Boundless Bio, Inc. Common Stock (2016–2024)
Financial flexibility index of Boundless Bio, Inc. Common Stock from 2016 to 2024. Historical Financial Flexibility Index trend for Boundless Bio, Inc. Common Stock across 7 annual periods. Explore BOLD debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Boundless Bio, Inc. Common Stock Financial Flexibility Index by Year (2016–2024)
Boundless Bio, Inc. Common Stock financial flexibility index by year from 2016 to 2024. Year-by-year free cash flow to debt coverage for Boundless Bio, Inc. Common Stock. For the full cash flow conversion analysis, see cash efficiency ratio of Boundless Bio, Inc. Common Stock.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.05x | $-58.30 Million | $-60.84 Million | $55.77 Million | ▼ -481.3% |
| 2023 | -0.18x | $-46.22 Million | $-46.85 Million | $256.98 Million | ▲ +26.0% |
| 2022 | -0.24x | $-38.53 Million | $-39.60 Million | $158.53 Million | ▼ -74.0% |
| 2021 | -0.14x | $-21.21 Million | $-23.25 Million | $151.91 Million | ▲ +95.7% |
| 2018 | -3.23x | $-96.37 Million | $-107.98 Million | $29.80 Million | ▲ +7.3% |
| 2017 | -3.49x | $-76.96 Million | $-84.51 Million | $22.06 Million | ▼ -144.5% |
| 2016 | -1.43x | $-32.37 Million | $-49.02 Million | $22.69 Million | — |